Articles

Editorial

10.4244/EIJ-D-26-00452 May 15, 2026
Inflammation after TAVI: an emerging therapeutic target?
Pilgrim T, Cozzi O
free

Editorial

10.4244/EIJ-E-26-00008 May 15, 2026
An unnecessary farewell? Drawing "accurate" lessons from DOUBLE-CHOICE
Blankenberg S, Ludwig S
free

Editorial

10.4244/EIJ-D-26-00417 May 15, 2026
A sledgehammer or a scalpel? Refining antithrombotic therapy in anticoagulated ACS patients
Gorog D, Toutouzas K
free

Viewpoint

10.4244/EIJ-E-26-00007 May 15, 2026
Full-on commitment to interventional cardiology – today and in the future
Prendergast B, Barbato E, Dumonteil N, Gilard M, Tchétché D, Cuisset T, Gonzalo N, of the PCR Board ob
free

Debate

10.4244/EIJ-E-26-00004 May 15, 2026
Prasugrel should be preferred over ticagrelor in acute coronary syndromes: pros and cons
Angiolillo D, Kastrati A, Frazzetto M, Valgimigli M
free

State-of-the-Art

10.4244/EIJ-D-25-00754 May 15, 2026
Timing of transcatheter aortic valve implantation in patients with aortic stenosis
Craig N, Prendergast B, Newby D, Dweck M
free

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L, Torres-Mezcua F, Herrero-Brocal M, Quesada Rico J, Ferrer R, Ballester S, Rocamora J, Siscar P, Valencia J, Torres-Saura F, López Clemente D, Riquelme C, López Clemente J, Palencia T, Ortiz de Salazar C, Rubio A, De la Hoz Marañón L, Mateo Soler J, Martínez J, Ruiz-Nodar J

Original Research

10.4244/EIJ-D-26-00001 May 15, 2026
Comparison of self-expanding transcatheter heart valves for aortic stenosis: the multicentre, randomised, controlled, non-inferiority DOUBLE-CHOICE trial
Feistritzer H, Lauten P, Rudolph T, Rudolph V, Geisler T, Massberg S, Adam M, Baldus S, Sossalla S, Joner M, Moellmann H, Wolf A, Kim W, Borger M, Noack T, Boening A, Bleiziffer S, Hohenstein S, Hoesler N, Buske M, Majunke N, Lankisch N, Roeder M, Desch S, Thiele H, Abdel-Wahab M, of the DOUBLE-CHOICE investigators o

Original Research

10.4244/EIJ-D-25-01337 May 15, 2026
Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudy
Holck E, Andreasen L, Neghabat O, Laanmets P, Mogensen L, Spratt J, Bennett J, Calic S, Walsh S, O’Kane P, Cockburn J, Henerah L, Chowdhary S, Grikis K, Lønborg J, Heighert M, Kische S, Christiansen E

Original Research

10.4244/EIJ-D-25-01373 May 15, 2026
Ticagrelor versus clopidogrel in orally anticoagulated patients with acute coronary syndrome undergoing percutaneous coronary intervention
Emilsson O, Mohammad M, van der Pals J, Braun O, Angerås O, Jernberg T, Zhou M, von Koch S, Erlinge D, Koul S
open access

Original Research

10.4244/EIJ-D-26-00161 May 15, 2026
Long-term clinical benefit after radiofrequency renal denervation: pooled 36-month results from the SPYRAL Clinical Program
Kandzari D, Böhm M, Schmieder R, Townsend R, Schlaich M, Kario K, Whitbourn R, Gilbertson M, Mahfoud F
open access

Letter to the editor

10.4244/EIJ-D-26-00224 May 15, 2026
Letter: Non-culprit plaque rupture in STEMI – marker of vulnerability or actionable risk?
Hudzik B
free

Reply to the letter to the editor

10.4244/EIJ-D-26-00287 May 15, 2026
Reply: Non-culprit plaque rupture in STEMI – marker of vulnerability or actionable risk?
Dai J, Zhao J, Yu B
free

PCR Column

10.4244/EIJ-E-26-00005 May 15, 2026
Strengthening your cardiovascular care pathway in times of disruption: a practical tool for European hospitals
Wijns W, Wallace S, the RESIL-Card consortium obo
free
Receive our newsletter


PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved